| Category | Antibody |
| Concentration | pH7, with 0, 02% sodium azide, 3, 5 mg/ml in 1X TBS, 5% BSA (US sourced) and 0 |
| Form | Antigen affinity purified |
| Conjugation | Unconjugated |
| Clone | Polyclonal antibody |
| Recognised antigen | TGF beta 2 / TGFB2 (pre-pro form) |
| Host animal | Goat (Capra aegagrus hircus) |
| Clonality | Polyclonal (goat origin) |
| Species reactivity | Cow, Dog, Due to limited knowledge and inability to test the antibody against all known species, Pig, we cannot guarantee that no other cross reactivity can occur, Human (Homo sapiens) |
| Tested applications | ELISA (peptide), WB |
| Recommended dilutions | 3-1ug/ml, ELISA (peptide) LOD: 1:32000, Western blot: 0 |
| Notes | Optimal dilution of the TGFB2 antibody should be determined by the researcher |
| Intented use | This TGFB2 antibodyis to be used only for research purposes and not for diagnostics |
| Uniprot # | P61812 |
| Purity | Antigen affinity |
| Description | G-TSF, Glioblastoma-derived T-cell suppressor factor, prepro-transforming growth factor beta-2, Additional name(s) for this target protein: Transforming growth factor beta 2 |
| Immunogen | This sequence is from the latency associated peptide region, Amino acids STYTSGDQKTIKSTR were used as the immunogen for this TGFB2 antibody |
| Storage | Celcius or lower, Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity, Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized, Aliquot and store the TGFB2 antibody at -20 deg |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24° |
| Gene target | TGF beta 2 / TGFB2 (pre-pro form) |
| Short name | TGF beta 2 Antibody / TGFB2 (pre-pro form) |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | b 2 (pre-L-proline form), TGF b 2 (Antibody to) / transforming growth factor |
| Alternative technique | antibodies |
| Alternative to gene target | Extracellular, LDS4 and TGF-beta2, TGFB2 and IDBG-106710 and ENSG00000092969 and 7042, TGFB2 and IDBG-629908 and ENSBTAG00000005359 and 534069, Tgfb2 and IDBG-208111 and ENSMUSG00000039239 and 21808, beta 2, protein heterodimerization activity, this GO :0000902 and cell morphogenesis and biological process this GO :0001501 and skeletal system development and biological process this GO :0001502 and cartilage condensation and biological process this GO :0001525 and angiogenesis and biological process this GO :0001540 and beta-amyloid binding and molecular function this GO :0001568 and blood vessel development and biological process this GO :0001654 and eye development and biological process this GO :0001666 and response to hypoxia and biological process this GO :0001837 and epithelial to mesenchymal transition and biological process this GO :0001942 and hair follicle development and biological process this GO :0001974 and blood vessel remodeling and biological process this GO :0002576 and platelet degranulation and biological process this GO :0003007 and heart morphogenesis and biological process this GO :0004702 and receptor signaling protein serine/threonine kinase activity and molecular function this GO :0005102 and receptor binding and molecular function this GO :0005114 and type II transforming growth factor beta receptor binding and molecular function this GO :0005125 and cytokine activity and molecular function this GO :0005160 and transforming growth factor beta receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005768 and endosome and cellular component this GO :0006468 and protein phosphorylation and biological process this GO :0007050 and cell cycle arrest and biological process this GO :0007179 and transforming growth factor beta receptor signaling pathway and biological process this GO :0007184 and SMAD protein import into nucleus and biological process this GO :0007267 and cell-cell signaling and biological process this GO :0007411 and axon guidance and biological process this GO :0007435 and salivary gland morphogenesis and biological process this GO :0007507 and heart development and biological process this GO :0007596 and blood coagulation and biological process this GO :0008083 and growth factor activity and molecular function this GO :0008219 and cell death and biological process this GO :0008283 and cell proliferation and biological process this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0008285 and negative regulation of cell proliferation and biological process this GO :0008347 and glial cell migration and biological process this GO :0009611 and response to wounding and biological process this GO :0009790 and embryo development and biological process this GO :0010002 and cardioblast differentiation and biological process this GO :0010628 and positive regulation of gene expression and biological process this GO :0010634 and positive regulation of epithelial cell migration and biological process this GO :0010693 and negative regulation of alkaline phosphatase activity and biological process this GO :0010718 and positive regulation of epithelial to mesenchymal transition and biological process this GO :0010936 and negative regulation of macrophage cytokine production and biological process this GO :0014068 and positive regulation of phosphatidylinositol 3-kinase signaling and biological process this GO :0016049 and cell growth and biological process this GO :0016477 and cell migration and biological process this GO :0022601 and menstrual cycle phase and biological process this GO :0023014 and signal transduction by phosphorylation and biological process this GO :0030097 and hemopoiesis and biological process this GO :0030168 and platelet activation and biological process this GO :0030198 and extracellular matrix organization and biological process this GO :0030199 and collagen fibril organization and biological process this GO :0030307 and positive regulation of cell growth and biological process this GO :0030308 and negative regulation of cell growth and biological process this GO :0030424 and axon and cellular component this GO :0030593 and neutrophil chemotaxis and biological process this GO :0031012 and extracellular matrix and cellular component this GO :0031069 and hair follicle morphogenesis and biological process this GO :0031093 and platelet alpha granule lumen and cellular component this GO :0032147 and activation of protein kinase activity and biological process this GO :0032570 and response to progesterone and biological process this GO :0032874 and positive regulation of stress-activated MAPK cascade and biological process this GO :0032909 and regulation of transforming growth factor beta2 production and biological process this GO :0033630 and positive regulation of cell adhesion mediated by integrin and biological process this GO :0040007 and growth and biological process this GO :0042060 and wound healing and biological process this GO :0042416 and dopamine biosynthetic process and biological process this GO :0042476 and odontogenesis and biological process this GO :0042493 and response to drug and biological process this GO :0042637 and catagen and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0042981 and regulation of apoptotic process and biological process this GO :0043025 and neuronal cell body and cellular component this GO :0043525 and positive regulation of neuron apoptotic process and biological process this GO :0045216 and cell-cell junction organization and biological process this GO :0045726 and positive regulation of integrin biosynthetic process and biological process this GO :0045778 and positive regulation of ossification and biological process this GO :0045787 and positive regulation of cell cycle and biological process this GO :0045823 and positive regulation of heart contraction and biological process this GO :0046982 and protein heterodimerization activity and molecular function this GO :0048103 and somatic stem cell division and biological process this GO :0048566 and embryonic digestive tract development and biological process this GO :0048663 and neuron fate commitment and biological process this GO :0048666 and neuron development and biological process this GO :0048699 and generation of neurons and biological process this GO :0050680 and negative regulation of epithelial cell proliferation and biological process this GO :0050714 and positive regulation of protein secretion and biological process this GO :0050777 and negative regulation of immune response and biological process this GO :0050778 and positive regulation of immune response and biological process this GO :0051781 and positive regulation of cell division and biological process this GO :0051795 and positive regulation of catagen and biological process this GO :0051891 and positive regulation of cardioblast differentiation and biological process this GO :0060038 and cardiac muscle cell proliferation and biological process this GO :0060317 and cardiac epithelial to mesenchymal transition and biological process this GO :0060325 and face morphogenesis and biological process this GO :0060389 and pathway-restricted SMAD protein phosphorylation and biological process this GO :0070237 and positive regulation of activation-induced cell death of T cells and biological process this GO :0097191 and extrinsic apoptotic signaling pathway and biological process this GO :2001241 and positive regulation of extrinsic apoptotic signaling pathway in absence of ligand and biological process, this GO :0001540: beta-amyloid binding, this GO :0001540: beta-amyloid binding and also this GO :0004702: receptor signaling protein serine/threonine kinase activity and also this GO :0005102: receptor binding and also this GO :0005114: type II transforming growth factor beta receptor binding and also this GO :0005125: cytokine activity and also this GO :0005160: transforming growth factor beta receptor binding and also this GO :0005515: protein binding and also this GO :0008083: growth factor activity and also this GO :0042803: protein homodimerization activity and also this GO :0046982: protein heterodimerization activity, this GO :0004702: receptor signaling protein serine/threonine kinase activity, this GO :0005102: receptor binding, this GO :0005114: type II transforming growth factor beta receptor binding, this GO :0005125: cytokine activity, this GO :0005160: transforming growth factor beta receptor binding, this GO :0005515: protein binding, this GO :0008083: growth factor activity, this GO :0042803: protein homodimerization activity, this GO :0046982: protein heterodimerization activity, transforming growth factor |
| Identity | 11768 |
| Gene | TGFB2 |
| Long gene name | transforming growth factor beta 2 |
| Synonyms gene name | beta 2 , transforming growth factor |
| Synonyms name | prepro-transforming growth factor beta-2 |
| Locus | 1q41 |
| Discovery year | 1989-05-10 |
| GenBank acession | M19154 |
| Entrez gene record | 7042 |
| RefSeq identity | NM_003238 |
| Classification | Endogenous ligands |
| Havana BLAST/BLAT | OTTHUMG00000039521 |
Technique
Supplier
Species
Label
Iso Type
Host
Tissue